Oral administration of prosultiamine improved the symptoms in patients with overactive bladder associated with HTLV-1-related myelopathy/tropical spastic paraparesis, and also reduced urinary biomarkers.

Abstract Category

Pharmacology

Links
	Abstract 573
	Pharmacology Scientific Open Discussion Poster Session 37
	Thursday 23rd October 2014
	13:30 - 14:30
	Poster Area
	Pharmacology Clinical Trial Overactive Bladder Neuropathies: Peripheral
	1. Department of Urology and Renal Transplantation, Nagasaki University School of Medicine, 2. Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University
Abstract PDF Edit Abstract Abstract Centre